Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Date: 03 August 2026 Ref. No.: TCPCL/SEC/2026-27/00033 The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E), Mumbai-400 001 Mumbai-400 051 Scrip Code: 543321 Scrip Symbol: TATVA Subject: Intimation of Schedule of Analyst(s)/Financial Institution(s)/Investor(s) Meeting Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting that the Company would be participating: Date Analyst(s)/Financial Type Mode Institution(s)/Investor(s) 06 August 2026 Mahindra Manulife Investment One to One Meeting Virtual Meeting Management Private Limited Please note that the above is subject to change, if any. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com. Kindly take above intimation on your record and oblige. Thanking you, Yours faithfully, For Tatva Chintan Pharma Chem Limited Ishwar Nayi Company Secretary and Compliance Officer M. No.: A37444